Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dr. Reddy's Continues to Grow
Yahoo/Zacks.com
Thursday, October 27, 2011 - 11:32am
tags:
Dr Reddy's, earnings
New job opportunities emerging in Big Pharma
Fierce Pharma
Thursday, October 27, 2011 - 11:20am
tags:
layoffs
Doctors Are Split On Avastin For Breast Cancer
Pharmalot
Thursday, October 27, 2011 - 11:12am
tags:
breast cancer, physicians, Avastin, Roche, Taxol
Gardasil Policy May Grow Coverage Without Reversing Sales Slide
Bloomberg Businessweek
Thursday, October 27, 2011 - 11:11am
tags:
HPV, Merck, Gardasil
Eli Lilly Is Overvalued, Pfizer More Attractive
Seeking Alpha
Thursday, October 27, 2011 - 11:07am
tags:
Eli Lilly, Pfizer, Sanofi, GSK
Pfizer's blockbuster pneumonia vaccine Prevnar 13 gets EU approval for adults 50 and older
Yahoo/AP
Thursday, October 27, 2011 - 11:06am
tags:
Pfizer, Prevnar 13, vaccine, Europe, pneumonia
AstraZeneca Q3 net profit boosted by disposal
Yahoo/AP
Thursday, October 27, 2011 - 9:29am
tags:
earnings, AstraZeneca
Bristol-Myers Tops Third-Quarter Profit Estimate
Bloomberg
Thursday, October 27, 2011 - 8:20am
tags:
earnings, Bristol-Myers Squibb
Another Round Of Milestone News Solidifies Ampio's Pipeline Potential
Seeking Alpha
Wednesday, October 26, 2011 - 6:14pm
tags:
Ampio Pharmaceuticals, Ampion, Daewoong Pharmaceuticals, Optina, diabetic macular edema, Zertane, premature ejaculation, osteoarthritis
Earnings Preview: Merck reports on third quarter
Yahoo/AP
Wednesday, October 26, 2011 - 6:12pm
tags:
earnings, Merck
Bristol Myers-AstraZeneca Diabetes Drug Delayed by U.S. FDA
Bloomberg
Wednesday, October 26, 2011 - 6:12pm
tags:
Bristol-Myers Squibb, diabetes, FDA, AstraZeneca, Dapagliflozin
Biotech 2011: Teva, Merck directors share views of biopharma industry
Med City
Wednesday, October 26, 2011 - 11:07am
tags:
Teva Pharmaceuticals, Merck, Biotech 2011
Mylan says CEO Coury to step down; shares rise
Reuters
Wednesday, October 26, 2011 - 11:04am
tags:
Mylan, Pharma CEOs, Robert Coury
Merck KGaA Advances Most Since 2009 as Profit Beats Estimates
Bloomberg
Wednesday, October 26, 2011 - 10:41am
tags:
Merck KGaA, earnings
Shire pump bypasses hurdle to sneak enzyme drug into brain
Fierce Drug Delivery
Wednesday, October 26, 2011 - 10:38am
tags:
Shire, Hunter Syndrome, Elaprase
Bayer and new partner Onyx crow over PhIII regorafenib success
Fierce Biotech
Wednesday, October 26, 2011 - 10:30am
tags:
regorafenib, ONYX Pharmaceuticals, Bayer, colon cancer
LABA Asthma drugs may increase attacks in kids: report
Reuters
Wednesday, October 26, 2011 - 10:29am
tags:
LABAs, long acting beta agonists, asthma, GSK, Serevent, Merck, Foradil, corticosteroids
3 Biotech Takeover/LBO Targets With Bullish Short Trends
Seeking Alpha
Wednesday, October 26, 2011 - 10:25am
tags:
M&A, Alnylam, Seattle Genetics, Exelixis
Allergan Shares Drop After Profit Forecast Missed Estimate
Bloomberg
Wednesday, October 26, 2011 - 10:18am
tags:
Allergan, earnings
Glaxo Third-Quarter Earnings Match Estimates
Bloomberg
Wednesday, October 26, 2011 - 9:13am
tags:
earnings, GSK

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.